ApoB Test May More Accurately Measure Heart Disease Risk
A study reveals that lipid panels may not fully capture the risk of cholesterol-related heart disease, highlighting a need for apoB testing.
Read MorePosted by Andy Lundin | Aug 13, 2024 | Cardiovascular |
A study reveals that lipid panels may not fully capture the risk of cholesterol-related heart disease, highlighting a need for apoB testing.
Read MorePosted by Chris Wolski | May 16, 2024 | Diabetes & Metabolic Diseases |
Luxor Scientific and CIMA Sciences have launched OWLiver, a non-invasive blood test to detect all stages of metabolic liver disease.
Read MorePosted by Andy Lundin | Mar 21, 2024 | Gastrointestinal Infections |
Lucid Diagnostics announced that a prospective VA screening study demonstrated strong performance of its EsoGuard Esophageal DNA test.
Read MorePosted by Andy Lundin | Jan 2, 2024 | Diabetes & Metabolic Diseases, Womens Health |
A new study evaluated the diagnostic value of certain markers before or at the time of screening for gestational diabetes mellitus.
Read MorePosted by Andy Lundin | Dec 5, 2023 | Cancer |
UCLA Researchers received $9.1 million in grant funding from the National Cancer Institute to advance liquid biopsy tech for cancer detection.
Read More